In this study, we found that the knockout of EGFL6 could affect the signaling pathways for ovarian cancer tumorigenesis, by activation of the integrin/Akt/mTOR and MAPK/Erk pathways. The gene discussed is MTOR; the disease is ovarian carcinoma.